Co-Diagnostics (CODX) Stock Price Target 2026

The average analyst price target for Co-Diagnostics is $90, 19989.3% above the current price. Of 3 analysts, 1 rates it Buy and 2 Hold. The latest change came on Jan 23, 2026, when Maxim Group downgraded Co-Diagnostics from Buy to Hold.

The Average Analyst Price Target for Co-Diagnostics is $90.

Price Target Range — 9 Quarters

Analyst Consensus — 3 Analysts

1Buy

2Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$90Upside to Avg. PT+19989.3%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Co-Diagnostics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jan 23, 2026	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—
Nov 26, 2025	Maxim Group	Jason McCarthy	Initiate	Buy	$45
Nov 24, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	—
Oct 28, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$90
Oct 16, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$90
Sep 19, 2025	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$300→$90
Sep 17, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$300
Aug 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$300
Apr 28, 2025	D. Boral Capital	Jason Kolbert	Initiate	Buy	$300
Mar 28, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$45→$30
Nov 11, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$45
Aug 12, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$60→$45
Jun 17, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$60
May 13, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$75→$60
Mar 15, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$90→$75
Dec 29, 2023	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$90
Nov 13, 2023	HC Wainwright & Co.	Yi Chen	PT Raise	Neutral	$60→$90